ENZ - Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp
2023-03-16 17:07:30 ET
- Enzo Biochem ( NYSE: ENZ ) on Thursday said it has sold its Clinical Laboratory division to Labcorp ( NYSE: LH ).
- Financial details of the transaction were not disclosed.
- “Completion of the sale will position Enzo to assess and execute on further actions to increase shareholder value and advance our global leadership within the life sciences sector,” Enzo CEO Hamid Erfanian said.
- Jefferies LLC served as exclusive financial advisor and McDermott Will & Emery LLP served as legal advisor to Enzo, and Evercore and Hogan Lovells served as advisors to Labcorp.
- Press Release .
- Shares +77.3% at $2.11 after hours.
For further details see:
Enzo Biochem stock surges 77% after divesting Clinical Labs unit to Labcorp